Assembly Biosciences's total assets for Q4 2024 were $119.17M, an increase of 18.86% from the previous quarter. ASMB total liabilities were $85.81M for the fiscal quarter, a 15.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.